Cetera Investment Advisers’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Buy
163,796
+10,082
+7% +$199K ﹤0.01% 1853
2025
Q4
$2.91M Sell
153,714
-3,673
-2% -$68.1K ﹤0.01% 1878
2025
Q3
$2.93M Buy
157,387
+50,235
+47% +$938K ﹤0.01% 1843
2025
Q2
$1.98M Buy
107,152
+2,203
+2% +$39.1K ﹤0.01% 1852
2025
Q1
$1.83M Sell
104,949
-291,132
-74% -$4.91M ﹤0.01% 1813
2024
Q4
$6.86M Buy
396,081
+25,160
+7% +$459K 0.01% 873
2024
Q3
$6.9M Sell
370,921
-43,131
-10% -$727K 0.02% 850
2024
Q2
$6.38M Buy
414,052
+7,377
+2% +$105K 0.01% 872
2024
Q1
$6.01M Buy
406,675
+103,413
+34% +$1.43M 0.01% 893
2023
Q4
$4.33M Buy
303,262
+6,908
+2% +$98.1K 0.04% 490
2023
Q3
$4.13M Buy
296,354
+13,553
+5% +$173K 0.04% 476
2023
Q2
$3.33M Buy
282,801
+8,334
+3% +$94.9K 0.03% 567
2023
Q1
$3.16M Buy
274,467
+185,514
+209% +$2.29M 0.03% 549
2022
Q4
$1.11M Buy
88,953
+6,577
+8% +$83.9K 0.01% 950
2022
Q3
$1.08M Buy
82,376
+1,504
+2% +$22.2K 0.02% 686
2022
Q2
$1.13M Buy
80,872
+264
+0.3% +$3.53K 0.02% 747
2022
Q1
$1.2M Buy
80,608
+919
+1% +$12.6K 0.02% 755
2021
Q4
$1.08M Buy
79,689
+65,221
+451% +$923K 0.02% 785
2021
Q3
$213K Buy
14,468
+454
+3% +$7.67K ﹤0.01% 1632
2021
Q2
$255K Buy
14,014
+1,315
+10% +$23.4K ﹤0.01% 1515
2021
Q1
$220K Buy
12,699
+594
+5% +$10.4K ﹤0.01% 1420
2020
Q4
$210K Buy
12,105
+1,972
+19% +$31.5K ﹤0.01% 1428
2020
Q3
$140K Buy
+10,133
New +$149K 0.01% 613
2020
Q2
Sell
-10,040
Closed -$110K 630
2020
Q1
$110K Buy
+10,040
New +$185K 0.01% 515

Other funds holding SBRA